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Antibiotic resistance genes (ARGs) may proliferate in surface water following the
discharge of treated wastewater effluent. Wastewater effluent often contains both
antibiotic residues, which may cause the emergence of ARGs in water microbiome
through mutation, and ARG-carrying bacteria, which can transfer ARGs to water
microbiome through conjugation. However, little is known about how environmental
factors affect these processes.
The goal of this study is to determine the effects of nutrient level and growth rate
on the proliferation of ARGs in surface water receiving wastewater effluent. Specifically,
the project investigated how environmental factors may affect the conjugation frequency
and mutation rate that confer ARGs to recipient cells, as well as the resistance level of the
recipient cells after mutation and conjugation. Chemostat reactors were built to simulate
surface water receiving wastewater effluent. Two E. coli strains, CV601 and J53, were
used as donor and recipient cells, respectively. First, CV601 cells received plasmids from
an actual wastewater effluent sample through filter mating and became resistant to
tetracycline. Then, J53 cells (i.e., to simulate water microbes) were established in
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chemostats before CV601 cells (i.e., to simulate wastewater microbes) were introduced.
Two nutrient levels (1/3 and 1/10 Muller Hinton broth) and two growth rates (0.15 and
0.45 hr-1) were tested.
Results show that regardless the nutrient level, the conjugation frequency was 10-2
and 10-6 for the high and low growth rate, respectively. The minimum inhibitory
concentration (MIC) of the recipient cells increased from 2 to 64-128 mg/L after the
conjugation tests. In addition, recipient cells grown under 0.45 hr-1 and 1/10 MHB
showed MIC increased from 2 to 8 mg/L in mutation experiment. Whole genome
sequencing verified the presence of a plasmid containing tetracycline resistance genes in
both the donor and the recipient cells, and identified the emergence of tetracycline
resistance genes in recipient cells following mutation.
This study generates quantitative information on the proliferation of ARGs in the
microbes of surface water receiving wastewater effluent. This information will allow for
better modeling and prediction of the risk associated with ARG proliferation in the
environment.
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CHAPTER 1. OVERVIEW
1.1 Antibiotic & Antibiotic Resistance Genes History
The era of antibiotics began in the 1940s where Sir Alexander Fleming introduced
penicillin. The discovery of penicillin has been recognized as one of the greatest
advances in human medicine 1. The therapeutic potential of penicillin was first explored
in the United Kingdom, and then during the World War II, the United States became the
leader of antibiotic production. Even though Sir Alexander Fleming warned the world
that an irresponsible use of antibiotics could lead to development of antibiotic resistance,
the wide consumption of penicillin seemed to be inevitable 2. The first bacterial resistance
against penicillin was observed in the 1960s, which forced scientists to look for a remedy
of this issue. The problem was solved by introducing and by developing of new series of
antibiotics. In the dawn of antibiotics development, the pattern of discovering new
antibiotics as a response of emerging resistance was continued, without taking into
account of combating antibiotic resistance 3. Eventually, the development of new
antibiotics becomes challenging and antibiotic resistant bacteria become prevalent. These
phenomena arose the necessity of rational use of the antibiotics and finding a way to stop
the emerging of antibiotic resistance in the environment.
Antimicrobial resistance (AMR) is now considered as an urgent global health
threat. The severity of the issue was highlighted by the World Health Organization report
that testifies the increasing incidence of resistance-induced health problems in every
region of the world 4. This led to the proposition of a “post-antibiotic” era whereby
common infections can no longer be effectively treated by antibiotics 5.
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1.2 Environmental Aspect of Antibiotic Resistance Genes (ARGs)
Antibiotic resistance constitutes a global public health threat. It has been
suggested that the contemporary resistance genes even originated in the natural
environment before the first antibiotic was discovered by human 6. Out of 30 lyophilized
E. coli strains isolated in 1946, four were resistant to 8 different antibiotics and their
resistance genes could be transferred to other E. coli through conjugation 7. In another
study, genes coding resistance to tetracycline, glycopeptide, and β-lactam were
discovered in a 30,000-year-old permafrost sediment, indicating resistance exists way
before mass production of antibiotics 8.
Studies have been shown that antibiotic resistant bacteria and associated
resistance genes are ubiquitous in the different environment compartments – from soil
and municipal wastewater systems to aquaculture facilities and animal husbandry
facilities 9. Durso et al. quantified the numbers and kinds of antibiotic resistance genes in
natural and agricultural samples from 26 different environments. They reported that
ARGs occur in natural, agricultural, and human-impacted habitats 10,11. More importantly,
the presence of resistance genes in different bacterial hosts suggests that resistance genes
can be easily transferred between different species. Accordingly, such studies frequently
state that the environment, an important reservoir of antibiotic resistant bacteria, poses a
risk for human health because these genes can be transferred to bacterial pathogens 12–15.
Most of the antibiotic resistance found in pathogens is acquired via mobile genetic
elements, and those resistance genes have been detected in natural environments. For
example, the qnrA gene that is associated with fluorquinolone resistance has been
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observed in aquatic environment 16.
In summary, our knowledge about abundance and occurrence of antibiotic
resistance genes in environments are expanding; however, little is known about how
environmental conditions may influence the rate and the dissemination of ARGs in
microbial population, which hampers our ability to generate reliable comparisons and
evaluation of the growth of ARG reservoirs in the environment 15.

1.3 Resistance Dissemination Mechanisms
Resistance can acquire through two distinct paths: vertical evolution, in which
selection of naturally occurring resistant mutants causing the development of antibiotic
resistance; or horizontal evolution, whereby acquisition of resistance genes occurs
through conjugation, transformation, and transduction 17.

1.3.1 Horizontal Gene Transfer
Horizontal gene transfer (HGT) refers to the ability of microbial species to
exchange genetic materials, other than genes transferring from parent cells to daughter
cells 18. Three main mechanisms of HGT are conjugation (i.e., the transfer of genetic
materials between two adjacently located bacteria by plasmids), transformation (i.e., the
uptake of extracellular DNA by competent bacteria), and transduction (i.e., the movement
of genetic material between species by bacteriophages) 19. Although these mechanism
often happen between closely related species, they can also occur between
phylogenetically distant organisms, increasing genetic variability over evolution history.
It has been reported that up to 17% of E. coli genome and up to 25% of genomes of other
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bacterial species is due to HGT event 20. In addition, horizontally transferred genes bring
about diverse functions into recipient cells, including antibiotic resistance, virulence
factors, and metabolic traits 21. Some ARGs occur on mobile genetic elements, which are
members of the communal gene pool available to a wide variety of bacterial species.
Therefore, the cross phylogenetic boundaries characteristic of HGT and the presence of
diverse mobile genetic elements carrying ARGs make HGT the main cause of spreading
antibiotic resistance in the environment 22.
1.3.1.1 Conjugation
Conjugation refers to the transferring of DNA from donor to recipient through
direct cell-to-cell contact. During conjugation, one bacterium serves as the donor and
another serves as the recipient. Once the two cells are in contact, either a circular doublestranded DNA (e.g., plasmid) or a single stranded DNA will be transferred from the
donor to the recipient 23. The new genetic materials often provides some genetic
advantage to the recipient 24. For example, the majority of genes transferred from donor
to recipient are ARGs which help recipient cells survive the presence of antibiotics.
These genes are typically transferred resistance in the form of plasmids 25.
A plasmid is an extrachromosomal genetic element that can independently
replicate. They are usually much smaller than the bacterial chromosome, varying from
less than 5 kbp to more than several hundred kbp, though plasmids as large as 2 Mbp
(i.e., megaplasmid) occur in some bacteria 26.
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Plasmids that can self replicate and that carry the genes needed for selftransmission are called conjugative plasmids. Plasmids that can only be transferred by an
outside machinery are called mobilizable plasmids 27. Plasmids are found in a wide
variety of environments and can be transferred across taxa. In addition, most broad-hostrange conjugative plasmids have been found carry ARGs 28. Conjugation is often
regarded as the main mechanism for the horizontal transfer of ARGs 29.
1.3.1.2 Transformation
Transformation is a process of HGT in which a bacterium acquires exogenous
DNA from the environment. Natural competence or the ability to acquire DNA from the
environment is a complex process 30. Transformation requires the expression of specific
genes and demands specific conditions. Some researchers argue that transformation does
not play a major role in spreading antibiotic resistance genes 31.
1.3.1.3 Transduction
Transduction refers to a process in which bacteriophages transfer DNA from one
bacterium to another. Transduction occurs when the phage attaches to its cognate
receptor on a host. Then, the phage integrate its genome into host genome and synthesize
the new genome to replicate 32. Due to the specificity between a phage and its host, it is
believed that transduction also has less impact on the dissemination of antibiotic
resistance genes between bacterial genera. However, further investigation is warranted as
transduction does not require physical contact (which is required in conjugation) and is
DNase resistant (as opposed to transformation).
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1.3.2 Vertical Gene Transfer
In 1859, Charles Darwin introduced term mutation whereby population gradually evolves
over the course of generations through natural selection 33. Mutation happens as a result
of errors in DNA replication during the transmission of DNA from parents to offspring.
Mutation is regarded as an most important process in bacterial evolution as it can happen
in every generation 34. Mutation is typically defined as heritable changes in genotype that
can occur spontaneously or be induced by a pressure in the environment such as chemical
presence, such as the emergence of antibiotic resistance in the presence of antibiotics 26.
Most of the mutations are nonfunctional and, thus, exchanging genetic materials between
different species seems more concerning in spreading of antibiotic resistance 35. The key
parameter in mutation is time and generation time. The higher the number of generation
there is, more mutations can potentially happen 36.

1.4 Antibiotic Resistance in Surface Water/Wastewater Treatment
Plant
Wastewater treatment plants are considered as an important reservoirs of
antibiotic resistance genes and hotspots for HGT, due to high diversity of bacteria, high
nutrient availability, and potential of biofilm formation 37–40. In addition to high diversity
and abundance of organisms, sewage has the trace of heavy metals, residuals of drugs,
pesticides, and many other toxic chemicals 41–43. Even advanced wastewater treatment
technologies cannot completely remove those contaminants 44. For example, the removal
efficiency of tetracycline in wastewater treatment has been reported from 12% 45 to 80%
46

. Hence, the treated effluent of WWTPs is still comprised of pollutants that not only can
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be entered to surface water and soils, and ultimately the chain food, but also can exert a
selective pressure, which may facilitate HGT. Moreover, biofilm formation (i.e., sludge)
as well as interface of different environment matrices may accelerate genetic exchange by
conjugation 47. A wide variety of broad-host-range plasmids, which can independently
transfer and replicate in broad range of phylogenetically distinct hosts, are often found in
WWTPs 48. Besides, broad-host-range plasmids can transfer mobilizable transposons
(nonself-transferable plasmids) encoding antibiotic resistance genes to hosts. WWTP thus
is a reservoir of communal antibiotic resistance genes and conjugative plasmids 25,49–51.
Some studies argue that preexisting genetic diversity and environmental selective
pressure in WWTPs can lead to horizontal and vertical gene transfer 52–56. However,
those studies used either unrealistically high concentration of antibiotics (mg/L) or
optimized conditions in terms of stress for bacteria population, which is not typical of the
environment. Indeed, the level of antibiotics that have been detected in surface water,
sewage, hospital effluents, and groundwater is generally on the orders of magnitude of
µg/liter and even ng/liter 57–59. Moreover, the fastest rate of plasmid transferring has been
observed at antibiotic concentration at around 10 µg/L 60. In the surface water
environments, bacterial populations are also influenced by environmental conditions.
However, the effects of environmental conditions on the conjugation frequency has not
been systematically studied.

1.5 Ecological/Environmental Factors
Even though the role of conjugation in disseminating ARGs has been recognized,
how environmental conditions affect conjugations under real environmental conditions is

18
not well understood. Generally, conjugation takes place when donor/recipient overcome
physiological, mechanistic, and selective barriers in the process 19,61. This means the
physiological state of donor and recipient as well as energy availability might drive the
process before and/or during conjugation. In a recent study, Hiltunen et al. used the ecoevolutionary dynamics framework to emphasize on community in spreading ARGs
(Figure 1.1). They highlighted that eco-evolutionary feedback is one of the reasons of
rapid evolution that we counter today. They argued that how combination of variety of
environmental factors – such as nutrient availability and antibiotic at sub-MIC level – can
change the population density and dynamics, and subsequently these changes cause
evolution. When evolution emerges, it can change the function(s) and/or structure of the
population 62. Therefore, in order to better understand conjugation in different
environmental compartments, a closer look at environmental/ecological factors that affect
population size and dynamic is appropriate.
Some of important environmental parameters that can affect conjugation rate
include: nutrient availability, temperature, pH, variation between different species, and
the environmental matrices 63,64. Although these environmental parameters are
measureable and quantifiable with current technologies, investigating the effect of
individual environmental parameter on conjugation frequency has been challenging. One
main reason is that gene transfer, particularly plasmid transfer, has been known as an
extremely complex process as it requires of simultaneous occurrence of several factors to
complete 65. In this regard, Lopatkin et al. investigated the effect of an antibiotic on
conjugation rate and demonstrated that the presence of an antibiotic does not necessarily
promote conjugation efficiency66. This statement is contradictory to traditional belief that
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antibiotics can increase conjugation rate due to its selective pressure impact 67.
Antibiotics can indirectly affect a wide variety of ecological parameters such as
population sizes, bacterial community composition, defense mechanisms in populations
due to cost of antibiotic resistance, and growth rate of bacteria. For example, if an
antibiotic does not affect both donor and recipient, there would not be any advantage for
transconjugants. Therefore, these results suggest that in a real-world scenario the
interaction and/or combination of different factors on different bacterial community
define conjugation mechanism.
Our understanding about conjugation efficiency can be advanced by considering
the effect of different environmental parameters separately. For example, it has been
suggested that the abundance and growth rates of different microbial populations play a
crucial role in conjugation rate 66. Growth rate is affected by multiple environmental
factors such as pH and temperature. In conclusion, the nutrient levels – which is related
to cell density – and growth rates of bacteria seem to determine the extent of conjugation
under various environmental conditions 64,68.
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Figure 1.1. Schematic of eco-evolutionary feedback loop 62.

1.6 Objectives
As ARG-carrying bacteria enter receiving water through WWTP discharge, they
interact with indigenous microbes under various environmental conditions. Background
nutrients and growth rates represent important environmental factors that can affect
conjugation process. The following objectives were investigated in this thesis:
I.

Understand the effects of bacterial growth rates and background nutrient levels on
ARG conjugation frequency and mutation rate in a simulated river setting

II.

Compare how the resistance level of recipient changes due to conjugation and
mutation under different environmental conditions

III.

Characterize the plasmids and mutations observed in part I and II.
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1.7 Overview of Approach
Batch reactor or filter mating approaches 69 cannot decouple the effects of
multiple parameters on conjugation. Hence, chemostat reactors are proposed as they
allow for separate investigations of growth rate and bacterial density 70. Continuous
cultures like chemostat can better simulate the natural environment such as river
comparing to batch reactors. Two important environmental factors (i.e., nutrient
availability and growth rate) were tested for their effects on horizontal and vertical
transfer of tetracycline resistance genes 71. Tetracycline was chosen as it is a widely used
antibiotic and is one of the most detected antibiotic in the surface water environments
72,73

. Environmentally relevant tetracycline concentration (i.e., 10 µg/L) was introduced

to the system with donor to mimic the discharge of WWTPs to the environment 74,75. In
order to elucidate the molecular mechanisms underlying the changes in MIC following
horizontal or vertical gene transfer, whole genome sequencing (WGS) was adopted. The
insight from bioinformatics/sequencing can reveal the molecular mechanism behind
phenotypical changes in bacteria.

1.8 Thesis Outline
This thesis consists of five chapters. Chapter One is a literary overview of
antibiotic resistance history, environmental framework of ARGs, antibiotic resistance
spreading mechanisms, and ARGs in surface waters. Chapter Two describes the protocols
and methodology used in this thesis. Results and discussion are presented in Chapter
Three. In Chapter Four, conclusions are summarized and ideas for future work are
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suggested. References and appendices including experimental setups, suppliers and parts
and supplementary information are listed at the end of this thesis.

CHAPTER 2. MATERIALS AND METHODS
2.1 Strains and Chemicals
Two Escherichia coli strains CV601 and J53 were obtained from Dr. Holger
Heuer of Julius Kühn Institute as donor and recipient cells, respectively, for the
conjugation study. This pair of strains have been used as model bacteria to study ARG
proliferation in several other studies 76–81. E. coli strain CV601 gfp is resistant to both
kanamycin and rifampicin and is tagged with gfp, which makes the cells green under UV
light 82. The E. coli strain J53 (F " met pro Azi& ), which is resistant to sodium azide, was
used as recipient cells in the conjugation experiments 83.
Tetracycline antibiotics often occur in wastewater streams entering the aquatic
environment, and their corresponding ARGs in rivers receiving the wastewater streams
84–86

. Tetracycline was used as the model antibiotic in this study. Tetracycline

hydrochloride (Sigma Aldrich, St. Louis, MO) stock solution, at 512 mg/L, was freshly
prepared and stored for no more than 7 days in 4°C. The stability of the stock solution
over the storage period was checked using high-pressure liquid chromatograph (HPLC)
in the Water Sciences Laboratory at UNL.
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2.2 Acquisition of Plasmid(s) Containing ARGs
Filter mating was employed to capture conjugative plasmids in the treated effluent
of Lincoln Theresa Street WWTP using E. coli CV601 as recipient cells. The filter
mating procedure used in this study was as described by Heuer et al. with slight
modifications including time of incubation, adding kanamycin to the media, and
temperature of incubation 82. Figure 2.1 shows the flowchart of the procedure.

Figure 2.1. Flowchart for capturing of conjugative plasmids containing tetracycline
resistance genes from the treated effluent of Lincoln Theresa Street WWTP.
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The glycerol stock of E. coli CV601 was cultured in lysogeny broth (LB) in the
presence of kanamycin (50 mg/L) and rifampicin (50 mg/L) with shaking at 30°C
overnight. The cell culture was then diluted 20 folds in fresh LB broth and grown for 10
hr to have recipient community in their exponential growth phase (Figure B1). The cells
were washed twice in phosphate-buffered saline (PBS) to remove the trace of antibiotics
and re-suspended in 15 ml of PBS.
Treated effluent was filtered through 0.45 µm pore size S-Pak filters (Millipore
Corporation, Bedford, USA). Bacteria were removed from the filters by vortex for 15 min
in 25 mL PBS. The bacterial suspension was decanted to a new tube and centrifuged for
15 min at 2700 ×g. rpm. The pellet was washed with PBS twice and re-suspended in
PBS. The volume of PBS was adjusted to reach an optical density at 600 nanometers
(OD600) of 1.4.
2 ml of effluent bacteria and 2 ml of CV601 were mixed and vortexed. 100 µL of mixture
was loaded onto a 0.22µm pore size mixed cellulose ester filter (Whatman plc inc.,
Maidstone, Kent, UK). Then, the filter was placed a LB agar plate amended with 100
mg/L cycloheximide and incubated at 37 °C for 2 days. Cycloheximide is an active
antibiotic against many molds, yeast, and phytopathogenic fungi 87. Therefore, we used
cycloheximide to remove undesirable organisms from WWTPs sample. After incubation,
the cell mixture on the filter disk was re-suspended in 2 mL PBS through vortex. The
suspension was plated on LB agar plates, which contained kanamycin (50 mg/L),
rifampicin (50 mg/L), cycloheximide (100 mg/L), and tetracycline (10 mg/L). As
controls, CV601 donor cells were grown and plated under the same conditions except the
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presence of cells from treated effluent. After 2 days, CV601 transconjugants receiving
plasmids from the treated effluent formed visible colonies on agar plates and their
identity was further verified using green fluorescence under UV light. The confirmation
of capturing tet-carrying plasmids was rechecked by minimum inhibitory concentration
test. The resulting CV601 (designated as “CW”), which contained tet-carrying plasmids,
was inoculated in selective liquid media and prepared as stock culture in glycerol and
stored in -80 °C freezer.

2.3 Chemostat Reactor Design
The experiment was conducted according to a 2×2 factorial design: growth
medium (1/3-strength and 1/10-strength Mueller Hinton Broth (MHB)) and growth rate
(0.15 and 0.45 hr-1). Two E. coli strains, CV601 transconjugants and J53, were used as
donor and recipient, respectively. First, E. coli J53 were cultured in LB broth in presence
of sodium azide (200 mg/L) at 35o C shaking overnight. Then, it was diluted to adjust OD
of 0.3, i.e., exponential phase (Figure B2). Finally, fresh E.coli J53 used in chemostat to
establish a steady state before CV601CW cells were introduced. All reactors contained
15 mL of E. coli J53 to simulate recipient cells in surface water. The experimental setup
was largely adopted from Dunham et al. with slight modification 71,88.
In each run, three replicate chemostat reactors were operated for one treatment
combination. The chemostat systems were established according to the procedure of
Dunham lab ministat manual 71. Parts and part numbers needed to establish the chemostat
reactor system is provided in Table A1. In brief, each chemostat reactor is made of a 50
mL pyrex tube with a 4-hole cap. The reaction solution volume is 30 mL. The growth
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medium was delivered from a 5 L carboy via a Watson Marlo pump at either 4 or 10
mL/hr to obtain the desired specific growth rates. Within each experimental run, all
reactors had the same dilution rate (i.e., 0.15 or 0.45 hr-1). In chemostat reactors, the
growth rate of a single culture is equal to the dilution ratio of the reactor at steady state.
To monitor if steady state has been reached, the cell density of recipient cells was
monitored by measuring optical density When the density of recipient cells reached
steady state in the reactors, tetracycline resistant CV601 donor cells and tetracycline were
added to the chemostat reactors through another carboy to reach final concentrations of
108 CFU/mL and 10 µg/L in the chemostat reactor. The time that the donor and antibiotic
was added was denoted as Day 0. 15 mL donor directly add to reactors and then the
donor line was inserted to the pump with the same flowrate as media. Since the flow rate
into reactor became double and the reactor volume also went up from 15 to 30 mL, the
dilution ratio kept constant. The experiments were repeated at least once for each dilution
ratio (i.e., 0.45 and 0.15 hr-1).
To account for the emergence of ARGs due to mutation, all the chemostat
experiments were repeated in the same manner without introducing the donor.
The samples were taken after 16, 24, 48, 72, and 96 hr to monitor conjugation
events. The number of donor, recipients and transconjugants were quantified using
culture-based method. At the end of experiments, samples were taken for whole-genome
sequencing.
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Figure 2.2. Schematic arrangement of chemostat reactor.
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2.4 Bacterial Enumeration
The viable plate count method was used to monitor number of transconjugants,
recipient, and donor in order to calculate conjugation frequency and control the
experiment conditions. All the samples were diluted in a 10-fold dilution series for each
reactor/technical replicate. For each dilution, plating was performed in triplicates. Colony
forming units (CFUs) for each run and plate was determined using the mean of the plate
triplicates, followed by the mean of the technical replicates (three per run).
For donor, frequent sampling events from the feed line and the rectors containing
donor cells was serially diluted in PBS and was plated on selective LB plates. After
incubation of 16 hr in 35o C, donor were selected on LB plates supplemented with
kanamycin (50 mg/L), rifampicin (50 mg/L), and tetracycline (10 mg/L).
Recipient cells were frequently sampled from the effluent line. Mixed culture
were serially diluted in PBS. Then, diluted recipient cultures were plated on LB plates
with sodium azide (200 mg/L). After 20 hr in 35o C, the number of recipient was
recorded.
For the selection of transconjugants, cultures directly were sampled from the
effluent of chemostat reactors and after serially diluted in PBS, they were plated on LB
supplemented with tetracycline (10 mg/L) and sodium azide (200 mg/L). The plates were
incubated for 24 hrs at 35o C. The same procedure was used to check mutation events in
recipients from mutation experiment.
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2.5 Calculating Conjugative Frequency
Conjugation frequency was expressed as the number of transconjugants per
recipient colonies formed as in equation 1 89.

Equation 1:

𝐶𝑜𝑛𝑗𝑢𝑔𝑎𝑡𝑖𝑜𝑛 𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 =

FGH
)
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LM@NONM>D? (
)
IJ

# 9: ;<=>?@9>ABC=>D?(
# 9:

2.6 Minimum Inhibitory Concentration Measurement
For the broth microdilution, stock tetracycline solution was serially diluted using
MH media into two-fold concentrations corresponding to 256 to 0.5 mg/L and carefully
dispensed into 96-well plate (VWR Company, Pennsylvania, USA). Inoculums of the
donor, recipient or transconjugants was diluted and the inoculated in each well except the
negative controls of the 96-well plate to achieve approximately 110 µL final volume in
each well. The plates were then incubated in a microplate reader (Biotek instruments,
Inc., Vermont, USA) at 37 ºC for a period of 16-20 hours to obtain growth curves by
continuous absorbance reading during incubation period. After the incubation period, the
plates were examined to further identify the MIC. The MIC was taken at the lowest
concentration of tetracycline that did not permit any visible growth 90.
Even though MIC is a single time-point measurement made after a fixed incubation
time, with the reader, it was clear that there is a substantial drop in light scattering at the
MIC compared to lower inhibitor concentrations.
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2.7 Whole Genome Sequencing and Assembly
Seven samples from different circumstances were chosen and sequenced using
Illumina Hiseq technology (Table 2.1). Total DNA, including plasmids and
chromosomes, was extracted using Qiagen DNA kit (Qiagen, Inc, Germantown, MD).
Sequencing reads, gene and plasmid assembly, and genome annotation analysis were
conducted in the Center for Biotechnology at University of Nebraska-Lincoln.
First, sequencing quality control was performed by FASTQC to check GC content
and quality of reads. Then, TrimGAlour was used to trim low quality bases from the 5prime and 3-prime reads and to remove reads that have on average low quality (i.e., Q30
and lower). Reads that contained no base were also removed. The remaining reads were
used to generate assembly via SPAdes (bacteria assembler) with multiple Kmer values.
After assemblies, the quality of each assembly was analyzed using QUAST. The average
sequence read length was 368 nucleotides and a total of 255 Mb was sequenced. Genome
annotation was conducted using Prokka with settings: kingdom bacteria and genomic
code 11. We allowed for overlaps between the coding regions of genes and rRNAs
region. In addition, we looked for noncoding RNAs in annotation. KAIJU looked at raw
reads and determined the lineage and family of bacteria. We uploaded the full genome to
Plasmid Finder to identify potential plasmids. We also utilized PLSDB database to
confirm the presence of the plasmids. Bowtie 2 was used to align samples. SAMtools and
BCFtools were utilized to generate and filter variant coding format files.
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Table 2.1 Samples for genomic sequencing.
Sample
#

Culture

Dilution
rate

Nutrient
concentration

Exp. Condition

1

Transconjugant

0.15 hr

-1

1/3 MHB

Conjugation

2

Transconjugant

0.45 hr

-1

1/3 MHB

Conjugation

3

Recipient

0.15 hr

-1

1/3 MHB

Mutation

4

Recipient

0.45 hr

-1

1/3 MHB

Mutation

5

J53

-

-

Original Culture

6

CV601

-

-

Original Culture

7

CV601+Tet

-

-

Transconjugant from
WWTP

2.8 Statistical Analysis
Multivariate analysis of variance (MANOVA) was conducted to evaluate the
significance of two nutrient backgrounds and growth rates on conjugation frequency and
number of transconjugants for each time point. All the statistical analysis was carried out
using TIBCO StatisticaTM.
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CHAPTER 3. RESULTS AND DISCUSSION
3.1 Establishing Steady State in Chemostat
One of the most important features of chemostats is that microorganisms can be
grown in a physiological steady state under constant environmental conditions 91. In this
steady state, growth occurs at a constant specific growth rate and all culture parameters
remain constant (i.e., culture volume, nutrient and product concentrations, pH, cell
density, etc.) 92. Therefore, one can independently set and control growth rate, cell
density, and selection pressure. In a chemostat reactor, dilution rate is the rate of media
volume addition relative to the reactor volume. At steady-state, the growth rate of
bacteria is equivalent to the dilution rate applied to chemostat reactors (Brock, 2012;
Herbert, Elsworth and Telling, 2009; Ziv, N., Brandt, N. J., Gresham, 2013). This enables
one to control growth rate of the culture by simply changing the speed of the feeding
pump.
The recipient cell J53 was inoculated in reactors and the speed of the pump was
adjusted to result in desirable dilution ratios (i.e., 0.45 or 0.15 hr-1). The literature reports
that the growth rate of E. coli in the environment has a range of 0.17 to 0.9 hr-1 95.
Considering the washout rate and the bacteriostatic effect of tetracycline, the dilution
rates of 0.15 hr-1 and 0.45 hr-1 were chosen to represent the low and the high growth rate,
respectively, in this study. The cell density in the reactor was monitored to determine if
steady state has reached. Reactors reached steady state after 1.5 and 3.5 days under high
and low dilution ratio, respectively (Figure 3.1). After reaching steady state, the growth
rate of recipient was technically set on dilution ratio and donor exposed to the reactors for
conjugation experiment.
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Figure 3.1. Density of recipient cells in triplicate chemostat reactors for 1/10 MHB and
1/3 MHB under 0.45hr-1 (a) and 0.15 hr-1 (b) dilution ratio.

3.2 The Effect of Growth Rate on Conjugation Frequency
The influence of growth rate on conjugation frequency was investigated.
Tetracycline was added to the chemostat reactors at an environmentally relevant
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concentration (i.e., 10 µg/L) to provide selective pressure 58,59. In addition, this
concentration appears to be sufficient to provide selective pressure for the transfer of
ARGs 60.
The higher growth rate led to higher conjugation frequencies (Figure 3.2). Under
the nutrient level of 1/10 MHB, the conjugation frequency was 8.08 ± 4.41 × 10-4 and
1.81 ± 2.21 × 10-6 at 16 hr for high and low growth rate, respectively, following the
addition of donor cells and tetracycline to recipient cells in the chemostat reactor. In
comparison, at the nutrient level of 1/3 MHB, the conjugation frequency was 8.94 ± 1.76
× 10-5 for bacteria grown under 0.45 hr-1 and 1.87 ± 2.48 ×10-6 under the growth rate of
0.15 hr-1. The results were reported only for 16 hr mating duration.
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Conjugation frequency (Number
of transconjugants per recipient)

0.15 hr-1
0.45 hr-1

1.0E-04

1.0E-05

1.0E-06
1/10 MHB

1/3 MHB

Nutrient Level
Figure 3.2. The effect of growth rate on conjugation frequency for 1/10 MHB and 1/3
MHB at 0.45 hr-1 and 0.15 hr-1 growth rate, in 16 hr mating duration.
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In the scientific literature, traditional conjugation procedures use a mating time
window of 16 hr. After 16 hr, the subsequent growth of transconjugants may
overestimate the conjugation frequency. Due to this fact, conjugation frequency is only
applicable in the traditional time window (i.e. 16 hr) 96. However, bacteria can share the
same habitat for days and even years in the environment, resulting in drastically increased
mating times. Therefore, the number of transconjugants was compared in lieu of the
conjugation frequency for the time points after 16 hr (Figure 3.3). Under the 1/10 MHB
nutrient level, the number of transconjugants increased from 9.83 ± 1.95 × 10 to 4.89 ±
4.37 × 103 CFU/mL and from 5.08 ± 5.32 × 10 to 3.69 ± 3.38 × 102 CFU/mL for 0.45 hr-1
and 0.15 hr-1, respectively (Figure 3.3. a). Similarly, under higher nutrient level (i.e., 1/3
MHB), the number of transconjugants showed an increase from 2.10 ± 0.32 × 102 to 4.19
± 2.88 × 104 for cultures grown under 0.45 hr-1. For bacteria grown at 0.15 hr-1, the
number of transconjugants was lower and in the same range for the course of experiments
– 1.18 ± 1.21 × 102 to 6.61 ± 6.18 × 102 (Figure 3.3. b).
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Figure 3.3. The effect of growth rate on number of transconjugants at 0.45 hr-1 and 0.15
hr-1 growth rate for a) 1/10 MHB and b) 1/3 MHB nutrient level. Errors bars are from six
replicate chemostat reactors.
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Main and interaction effects of nutrient level and growth rate were assessed using
a multivariate repeated measures analysis of variance, where response variables were logtransformed concentrations of transconjugants and replicates. An identical repeatedmeasures ANOVA was also conducted where conjugation rate was the response
variable. MANOVA showed significant main effects of both nutrient level (F2, 19 =
30.5, P < 0.001) and growth rate (F2, 19=246.3, P < 0.001), with Tukey’s post-hoc test
showing significantly higher in lower nutrient level (P < 0.001) and higher growth rate (P
< 0.001). MANOVA also detected a significant interaction effect of nutrient level and
growth rate (F2, 19 = 5.1, P=0.02), with post-hoc tests showing significantly higher at 0.45
hr-1 growth rate (P = 0.004) and 1/10 MHB (P = 0.0170).
These results can be explained by two concepts: 1) different number of
generations for the two growth rates at each time point; 2) fitness cost to bacteria in the
community.
For a given experimental duration, a higher growth rate means a larger number of
generations. The doubling time associated with the growth rates of 0.45 hr-1 and 0.15 hr-1
was 1.54 hr and 4.62 hr, respectively. In other words, the number of generations of the
cultured cells associated with the dilution rate of 0.45 hr-1 was always three times the
number of generations associated with the dilution rate of 0.15 hr-1. For example, after 72
hr of the introduction of donor cells and antibiotic, 48 generations had occurred under the
dilution rate of 0.45 hr-1 while only 16 generations had occurred for 0.15 hr-1.
Interestingly, the number of transconjugants at the same generation numbers were the
same for the similar nutrient condition (Figure C1). In fact, the trend of increased number
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of transconjugants showed that cultures grown under similar nutrient concentration had
the same number of transconjugants at the same generation numbers, regardless of the
growth rate in the reactors. Therefore, slow growing bacteria can show the similar
number of transconjugants compared to fast grow bacteria if they reach at the same
generation numbers.
Another well-studied reason for these results is fitness cost. Previous studies
showed that HGT can provide an initial selective advantage or may subsequently affect
the fitness cost of the recipient 97–99. Adaptive genes provide a selective advantage for the
recipient and have a higher chance of persisting over long periods of time 24. As their
frequency in the population increases over time, these genes become fixed. Since the
number of generations was lower at a low growth rate, the transferred genes had not yet
fully adapted to the genome and regulatory environment of the recipient. Therefore, it is
possible that the plasmid did not decrease the fitness cost of transconjugants with a low
growth rate and therefore transconjugants were unable to take over the community
population. On the other hand, new genes in the recipient may fix faster and consequently
provide a selective advantage to the recipient with a high growth rate during the course of
the experiment, resulting in a higher number of transconjugant. It is worth noting that a
previous study showed that 10 µg/L of tetracycline increased the transfer frequency by
two-fold for several ARGs 60, indicating that optimal experimental conditions contribute
to the transfer of the plasmid and had the highest transfer frequency in both scenarios.
Moreover, fitness cost is an important factor for a bacterium in a population, especially
when a stressor is present. Thus, 10 µg/L tetracycline and competition for food sources
can result in cells with lower fitness costs, which can dominate the environment over
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time. Higher growth rates placed a dual stress on bacteria as compared to low growth
rates. Therefore, with a higher growth rate, it is likely that the recipient (J53) was
outcompeted by transconjugants.
As previously mentioned, donors can be either CV601 or transconjugants J53
after the initial conjugation event. Since conjugation is a cell-to-cell contact process,
increasing the number of potential donors increases the chance of plasmid transfer.
However, the effect of secondary transconjugant donors was ignored because we were
unable to confirm that J53 was as capable as the original donor for transferring plasmid.

3.3 Effect of Nutrient Background on Conjugation Frequency
Nutrient concentration is one of the most impactful parameters affecting
conjugation efficiency 100. The effect of nutrient level on conjugation frequency was
investigated at 16 hr time-point (Figure 3.4). Under the growth rate of 0.45 hr-1, the
conjugation frequency was 8.94 ± 1.76 × 10-5 and 8.08 ± 4.41 × 10-4 for high and low
nutrient level, respectively. In comparison, at the growth rate of 0.15 hr-1, the conjugation
frequency was 1.87 ± 2.48 ×10-6 for bacteria grown under 1/3 MHB and 1.81 ± 2.21 × 106

under the grow of lower nutrient level (i.e., 1/10 MHB).
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Figure 3.4. The effect of nutrient level on conjugation frequency at 0.45 hr-1 and 0.15hr-1
growth rate for 1/10 MHB and 1/3 MHB nutrient level, in 16 hr mating duration.

Although a lower nutrient background was associated with a slightly higher
transfer frequency at 0.45 hr-1, ANOVA showed that there was no significant effect of
nutrient level on conjugation rate, however a main effect was observed for growth rate (F
= 90.3, P <0.001); thus, nutrient concentration had no effect on transfer frequency. This
result is unexpected, as Lopatkin et al. (2016) showed that conjugation frequency
significantly increased when the concentration of glucose was increased in the medium.
However, one reason for this contradictory result is Lopatkin et al. conducted their
experiment in a batch system and in the absence of additional stressors, indicating that
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competition between donors, transconjugants, and recipients was not considered in their
experiment. Since the energy source (i.e., nutrient level) is correlated with growth rate in
a batch system, increased energy availability leads to a faster growth rate. In addition, it
is not clear how different bacteria use energy sources in the process of transferring
genetic material through conjugation. Therefore, it seems likely that nutrient
concentration does not independently drive conjugation efficiency, suggesting other
factors, such as growth rate under the influence of nutrient concentration, impact
conjugation frequency.
Similar to previous part, the number of transconjugants were compared for two
nutrient levels grown under the same growth rate during the course of experiments
(Figure 3.5).
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Figure 3.5. The effect of nutrient level on number of transconjugants for 1/3 MHB and
1/10 MHB nutrient level at a) 0.45 hr-1 and b) 0.15 hr-1 growth rate. Errors bars are from
six replicate chemostat reactors.
MANOVA exhibited no significant interaction effect on number of transconjugants
for different nutrient backgrounds in different growth conditions.
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The nutrient concentration defines the cell density in the chemostat reactor (Ziv,
N., Brandt, N. J., Gresham, 2013). Therefore, higher nutrient level led to higher cell
density. Since the number of transconjugants can be the summation of conjugation event
and subsequent growth of transconjugants, the slight higher number of transconjugants in
higher nutrient availability was due to the higher cell density of transconjugants.

3.4 Minimum Inhibitory Concentration Change
To determine the effect of the plasmid transfer from donor to recipient, minimum
inhibitory concentration (MIC) for tetracycline were measured under different growth
conditions (Figure 3.6). The MIC test showed the immediate increase in resistance level
for transconjugants probably due to plasmid transfer. The MIC of transconjugants
increased from 2 to 128 mg/L and 2 to 64mg/L for high and low growth rate,
respectively, regardless of nutrient level.
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Figure 3.6. Change in MIC relative to J53 control for tetracycline, following 4 days of
conjugation experiment under 0.45 hr-1 and 0.15 hr-1 growth rate for either 1/10 MHB or
1/3 MHB in the reactor.
Since different nutrient background had the similar effect on increasing MIC
value for transconjugants, the transconjugants’ MIC were influenced by growth rate,
being 2-fold higher at 0.45 hr-1 than at 0.15 hr-1. Comparably, the MIC for the donor
increased from 2 to 256 mg/L after receiving plasmid from WWTP in the filter mating
experiment. As observed, the change in MIC in transconjugants was unexpectedly lower
than donor although they had the same plasmid, 2-fold in high growth rate and 4-fold in
low growth rate. The increase in MIC in transconjugants could not be because of
mutation as MIC changed in mutation experiment was insignificant, 2 to 4 mg/L. To
check the presence of the plasmid in recipients and explain why the MIC of
transconjugants and original donor is not exactly the same, the genomic of donor,
recipient and transconjugants were studied.
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3.5 Effect of Growth Rate on Mutation
Both high and low growth rate resulted in MIC ranging between 2 and 4 mg/L for
1/3 MHB nutrient level after 96 hours of the experiment. The only exception was the
higher growth rate in lower nutrient level, which showed an increase MIC from 2 to 8
mg/L (Figure 3.7).
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Figure 3.7. Change in MIC relative to J53 control for tetracycline, following 4
days of mutation experiment under 0.45 hr-1 and 0.15 hr-1 growth rate for 1/10 MHB in
the reactor.
For decades, it has been believed that bacteria growing faster are typically more
susceptible to antibiotics than bacteria that are slow growing 101. However, our results
showed that the susceptibility of a culture is likely independent of growth rate, at least for
a short time. A simple explanation is that most of the studies have been conducted in the
batch reactors, meaning the term growth rate has been basically used for the metabolic
state rather than growth rate. In this context, the correct statement will be susceptibility is
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less notable for stationary phase cells compared to exponentially growing. In the current
experimental set-up, MIC was measured during the exponential growth phase, for the two
growth rates. In this case, having cells in their healthiest stage of growth, the number of
generation, nutrient availability, and the tetracycline stressor can affect either the
emergence or proliferation of resistant colonies, denoting that even growth rate cannot be
exclusively considered as mutation-driven factor. Therefore, the slight increase in MIC
for higher growth rate/low nutrient availability toward the end of the experiments cannot
be related only to growth rate. In addition, the culture-based MIC measurement reports
the result based on the most resistance cells within the inoculation 102. Therefore,
emergence of limited mutants could increase the overall MIC of the culture. Existing
resistance colonies can be either because of their preexisting in the culture or better
fitness cost compared to susceptible colonies in the more stressful condition (i.e., higher
growth rate/low nutrient level).

3.6 Effect of nutrient background on mutation
The effect of nutrient availability on vertical gene transfer (i.e., mutation) was
insignificant in the course of experiments (Figure 3.8). Although a bit increases in MIC
was only observed for higher growth rate toward the end of experiments, the change in
MIC for both nutrient backgrounds was the same.
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Figure 3.8. Change in MIC relative to J53 control for tetracycline, following 4
days of mutation experiment for 1/10 MHB and 1/3 MHB under a) 0.45 hr-1 and b) 0.15
hr-1 growth rate in the reactor.
For mutation experiments, the pure culture of J53 was inoculated in the reactors.
As we used continuous reactors, the nutrient concentration solely defined the cell density

49
and did not affect growth rate. Since the same effect on MIC was observed in conjugation
experiments for higher growth rate, we can conclude that generation time or growth rate
is a key term for mutation rather than nutrient concentration. Following these results,
long-term evolution experiments reported that the genome is highly dynamic and
evolving genomes become increasingly different in descendants from ancestor, increasing
the probability of emerging beneficial mutations and consequently change in phenotypic
characteristics 103.
4.7 Whole Genome Sequencing
To confirm the transfer of tetracycline resistant plasmids from the donor cells to
the recipient cells, whole genome sequencing was conducted to compare the genome of
donor, recipient, and transconjugants. The sequence of all possible plasmids was
examined in the donor to identify tetracycline resistance genes (Table C2). Out of the
seven plasmids identified, the CW_60 plasmid was the only plasmid that contained
known tetracycline resistant genes (i.e., tetA and tetR). Figure 3.9 shows the fully
assembled the CW_60 plasmid.
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Figure 3.9. The sequenced plasmid in donor annotated for the tetracycline resistance and
other known genes.
The sequence of CW_60 will be submitted to GenBank. The sequence of the
CW_60 plasmid was searched against databases to check if it matches any known
plasmid. The CW_60 plasmid shared more than 98% nucleotide sequence identity with
plasmids in E. coli, Salmonella enterica, Klebsiella pneumonia, Shigella flexneri and
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Shewanella algae strains. Table 3.1 shows four plasmid entries, out of all BLAST hits,
containing sequences similar to the CW_60 plasmid.

Table 3.1 Identical plasmids to CW_60 in other studies.
Description
Uncultured
bacterium IncP-1beta
multiresistance
plasmid pB10
Salmonella enterica
subsp. Tetracycline
and ampicillin
resistance
transposons Tn1721like an Tn3-like in
plasmid pUO-SoR1
Escherichia coli
strain 2009-52
plasmid psDJ200952F
Escherichia coli
strain MRSN352231
plasmid
pMR0716_tem1

CW_60
Coverages

Resistancesb

Reference

100 %

Merr Smr Ter

104

100 %

Sur Smr Ter SxTr APr

105

100 %

APr SxTr Ter Smr

106

100 %

Amcr Cfr Clr Enr Ter SxTr Ter FEPr
CAZr IMPr

107

b

AP, ampicillin; Amc, amoxicillin-clavulanic acid; Cf, cephalothin; Cl, colistin; Sm,
streptomycin; Su, sulfonamides; Te, tetracycline; SxT, trimethoprim-sulfamethoxazole.

For example, plasmid pB10 was isolated from a wastewater treatment plant in
Germany and mediated resistance to the antimicrobial agents tetracycline, amoxicillin,
streptomycin, and sulfonamides 104. They mentioned that the plasmid may rapidly spread
among bacterial populations due to the transposons and integrons on it. In another study,
a similar plasmid was found in 54 isolates of the foodborne pathogen Salmonella enterica
serovar Ohio 105. Two large conjugative plasmids similar to CW_60 contained ARGs
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corresponding to tetracycline, streptomycin, trimethoprim, sulphonamides, ampicillin,
gentamicin, kanamycin, and chloramphenicol. Lastly, plasmid psDJ2009-52F, which
shared 99 percent identity with CW_60, was recovered from two E. coli strains isolated
from a patient in Sydney Adventist Hospital (Sydney, NSW, Australia). The E. coli
strains containing psDJ2009-52F showed reduced susceptibility to ampicillin,
trimethoprim, sulfamethazole, tetracycline, and streptomycin 106.
The size of CW_60 compared to similar plasmids in databases indicated that
CW_60 is likely part of a megaplasmid, which is prevalent in the environment.
Moreover, the presence of similar plasmids in different bacteria genre demonstrated that
the plasmid can be easily transferred between different species via horizontal gene
transfer. Here, CW_60 was completely transferred to recipient grown under 0.45 hr-1
growth rate (i.e., T45), and only was 8 bases shorter in transconjugants (Figure 3.10).

53

Figure 3.10. Comparison of CW60 plasmid in donor (i.e., purple circle) and
transconjugants (i.e., green circle) grown at 0.45 hr-1. The small open area on the top of
green circle confers the plasmid in transconjugants were 8 bases shorter than the plasmid
in donor.

We could not find CW_60 in transconjugants grown under the growth rate of 0.15
hr-1 (i.e., T15). However, other plasmids that were present in donor and T45 were found
in T15 (data not shown). The absence of CW_60 in T15 could be due to fragmentation.
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These results proved that a mobilizable plasmid containing tetracycline resistance genes
were transferred from WWTP effluent to donor, and then later from donor to recipient.
The second question that we tried to answer was the discrepancy in MIC level
between donor and transconjugants grown under high and low growth rate. The CW_60
was the reason for the increase in MIC in donor and T45. Comparably, there was not any
particular evidence to explain lower MIC in T15 compared to donor and T45. In addition,
genomic study is not sufficient to answer this question as this difference in MIC can
probably due to the experimental condition, heterogeneity of MIC of colonies in the
culture, and compatibility of plasmid 108. Therefore, further studies needed to assess wide
variety of possible parameters and reveal the mystery.
To check mutation events, genome of the recipient grown under different growth
rate were assembled (i.e., M45 and M15 for mutants grown under 0.45 hr-1 and 0.15 hr-1
growth rate, respectively). There were only three mutation events in M15 compared to
original recipient (Table 3.2).
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Table 3.2 Mutations in recipient grown at 0.45 hr-1 and 0.15 hr-1.
Sample

Gene Symbol
yaaA

yfgI
tehA
rclC

W R 28;

hslJ

A P 14; N I 94; L V 134;

nohD
M15

A E 73; D A 242;
T A 243; T A 292; V M
345;
L F 5; I V 54;
A T 60;

cbrA
M45

Mutation

E * 82; E Q 84;

insH-5

I V 83; A P 117; K E 185;
G S 187; H N 190;

pinQ

E G 38; K * 82; D A 194;

Description
peroxide stress resistance protein
YaaA
colicin M resistance protein
nalidixic acid resistance protein YfgI
tellurite resistance protein
reactive chlorine species resistance
protein C
lipoprotein implicated in Novobiocin
resistance
DLP12 prophage%3B putative DNApackaging protein NohD
Rac prophage%3B IS5 transposase
and trans-activator
Qin prophage%3B putative sitespecific recombinase

The first mutation in T15 was found in nohD gene. This gene is typically near a
site of targeted chromosome cleavage by lambda terminase that introduces double-strand
cleavages in DNA 109. Therefore, the mutation happened in nohD is part of DNA
recombination and there was no beneficial function for recipient to combat tetracycline.
The second mutation in T15 was on insH-5 gene. InsH-5 interacts with the termini of the
IS5 sequence 110. The IS5 can enhance gene transcription when it is placed on either side
of the promoter for a target gene 111. Hence, the interaction between insH-5 and the IS5
sequence plays a key role in transcription enhancement. The exact function of insH-5 in
combating antibiotic resistance is not clear. The third mutation in recipient grown under
the lower growth rate was on the pinQ gene. There was no information about the
involvement of pinQ in antibiotic resistance. We concluded that all mutations happened
in recipient grown at 0.15 hr-1 was not related to antibiotic resistant capability. The
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phenotypical characteristics of recipient and M15 confirmed our conclusion as they
showed similar MIC level.
On the other hand, the MIC for M45 was 8 mg/L which was 4 times higher than
that for the original recipient. Genomic results showed six mutations on the M45 genome
(Table 3.2). Between those mutations, yaaA was peroxide stress resistance protein,
which may play a role in tetracycline resistance. This mutation likely happened due to a
stress response of recipient in reaction to tetracycline presence, a process known as
stringent response 112. It showed that tetracycline produces lethal oxidative stress to kill
the bacteria 113. This means for cells facing oxidative stress induced by tetracycline, they
produced antioxidant enzymes to survive 114. In addition, yaaA prevents oxidative
damage to both DNA and proteins by diminishing the amount of unincorporated iron
within the cell 115. The higher MIC for recipient grown at 0.45 hr-1 compared to recipient
may also be attributed to the mutation in the yaaA gene.
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CHAPTER 4. CONCLUSIONS AND FUTURE WORK
4.1 Conclusions
Wastewater treatment plants are often considered as hotspots for ARGs and mobile
genetic elements. The treatment processes are not able to completely remove antibiotics
or ARGs from wastewater. Therefore, the wastewater effluent from WWTPs often
contains a wide variety of antibiotics and ARGs, which can subsequently cause the
proliferation of ARGs in receiving water bodies. Although the role of the environment in
spreading ARGs has been recognized, our understanding of this risk is still limited. Here,
the effects of nutrient level and growth rate on the vertical and horizontal transfer of
ARGs in surface water receiving wastewater effluent were investigated. From this
research, the following conclusions can be made:
•

Higher growth rate exhibited higher conjugation frequency than lower growth rate.

•

Nutrient level had not significantly impact on conjugation frequency under
different growth conditions.

•

The number of transconjugants in the reactors is correlated to generation numbers
in the reactor.

•

The resistance level was higher for cells receiving ARG-bearing plasmids through
HGT than cells acquiring ARGs through mutation.

•

Whole genome sequencing confirmed transfer of ARG-bearing plasmid between
E. coli cells.
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4.2 Future Work
Recently, mathematical models have been introduced as a simple tool to enhance our
understanding of the emergence, spread, and persistence of ARGs in the environment 116–
118

. These mathematical models can lead us to find knowledge gaps and identify

parameters and processes that are important in estimate the risk of ARGs in the
environment. One advantages of modelling is that once calibrated models can be used to
simulate different environmental conditions, which would be expensive to test in the lab.
Mathematical models for plasmid transfer in batch systems, biofilm, and solid surface
have successfully been explored 119–121. For example, the ‘end point’ approach by
Simonsen et al. is one of the most popular models in plasmid transfer in a batch system
122

. However, due to the complexity in operation, continuous cultures (chemostat) has not

been used for plasmid transfer experiment, let alone being modelled. However, the
mathematic principal of chemostat reactor has been extensively studied and wellunderstood. Hence, this experimental design is a promising approach in order to better
understand the circumstance in the environment using data acquired from chemostat
reactors. Then, by establishing a model calibrated using the data from the chemostat
reactors, we will be able to predict the proliferation of ARGs in surface water under other
environmental conditions.
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APPENDICES
Appendix A. Chemostat Parts and Suppliers
Table A1. Parts and Suppliers
Tubing, connectors, and clamps
Source
1/16" x 1/8" silicone tubing
VWR
(tiny)
3/32” x 7/32” silicone tubing
VWR
(small) (3/32" tubing uses 1/8"
connectors)
1/4” x 3/8” silicone tubing
VWR
(medium)
1/2" x 5/8" silicone tubing
VWR
(extra large)
orange green pump tubing, pre- Watson-Marlow
assembled
Short Blunt Needle for pump
Brico Medical
tubing, 24 Gauge x 1/2" Length
Supplies
Male luer connector to 1/16"
Cole Parmer
barb
reducing connector, PP, 3/32"
Cole Parmer
to 1/16"
female luer, 1/8" barb, PVDF
Cole Parmer

Item
89068-468
63009-260
63009-279
63009-299
978.0038.000
BN2405
EW-45513-00
EW-30621-95
EW-45512-04

male luer lock, 1/8" barb

Cole Parmer

HV-45503-04

barbed Y connector, 1/8" ID

Cole Parmer

HV-30703-92

male luer slip, 1/8" barb

Cole Parmer

HV-45503-26

Quantity
50' coil
pack
50' coil
pack
50' coil
pack
50' coil
pack
pack of 6
pack of
1000
pack of
25
pack of
25
pack of
25
pack of
25
pack of
10
pack of
25
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reducing connector, PVDF,
1/4" to 1/8"
Male Inline valved connector,
Fits tubing: 1/4 in. I.D.,
Polypropylene
Female Inline valved connector,
Fits tubing: 1/4 in. I.D.,
Polypropylene
large tubing clamps, 12-position
medium tubing clamps

Cole Parmer

EW-30703-50

Fisher

05-112-39

Fisher

05-112-37

pack of 5

VWR
VWR

63022-407
63022-405

small tubing clamps

VWR

63022-403

Day Pinchcock (metal clamp
for tubing)
Assorted zip ties
Silent Air Pumps

VWR

21730-001

pack of 6
pack of
12
pack of
1000
pack of
10

VWR
Aquarium
Guys.com
Fisher

21800-000
212422
R04SP02500

Fisher

K953715-0801

Cole Parmer
Air-Tite
Products Co.,
Inc.

EW-06464-85

Cole Parmer

EW-06298-06

Air-Tite
Products Co.,
Inc.
VWR

NB20112
16171-004

VWR

EW-06298-22

VWR

89001-530

Watson-Marlow

020.3716.00A

VWR

12621-120

PTFE filters, 0.45 µ, for air
filtration
#8 silicone stopper, 3/8 in. hole,
for babystat bubblers, for
vacuum flasks
4 port manifold
hypodermic needle, 16G, 5 in.
length (for effluent line)
BD Spinal needles, 18G 6 in.
length (for air line)
hypodermic needle, 20G, 1.5 in.
length (for media line)
Foam Silicone stopper,
nonstandard size "2", pink
Blunt Needles for effluent cork,
20 Gauge x 1-1/2" Length
100 ml bottles for effluent
Foam Silicone stopper, nonstandard size 12
5 L Reservoir bottle with
bottom hose outlet
205S/CA16, 16 channel
cartridge pump
6-block dry bath

pack of
10
pack of
25

each
box of
100

pack of
20
pack of
1000
case of
48
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Figure B1. Growth curve of E. coli CV601
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Figure B3. Number of donor in feed reservoir for conjugation experiment grown under a)
0.15 hr-1 and b) 0.45 hr-1
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Figure B4. Number of donor in chemostat reactors for two nutrient levels in conjugation
experiment grown under a) 0.15 hr-1 and b) 0.45 hr-1
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Figure B5. Number of recipient in chemostat reactors for two nutrient levels in
conjugation experiment grown under a) 0.15 hr-1 and b) 0.45 hr-1
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Figure C1. Number of transconjugants in the chemostat reactors for two nutrient levels
(i.e., 1/10 MHB and 1/3 MHB) and two growth rates (i.e., 0.15 hr-1 and 0.45 hr-1)
following the number of generations in conjugation experiment.
Table C2. Possible plasmid presented in donor based on genome content and searching
against databases.
ID

length

Gene Content

CW_24
CW_34
CW_47
CW_56
CW_57
CW_59
CW_60
CW_65

84152
33413
10104
4636
4497
4042
3952
2210

49
55
47
59
60
43
62
53

Is Plasmid? (Blast, PLSDB,
PlasmidFinder)
Y, Y, Y
Y, Y, Y
Y, Y, N
Y, Y, Y
Y, Y, N
Y, Y, N
Y, Y, N
Y, N, N
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Appendix D. Chemostat Protocols
Table D1. A day by day chemostat set-up protocol:
A. Day 1:
I.
II.
III.
IV.
V.
VI.
B. Day 2:
I.
II.

Clean all the reactors’ part.
Set up the reactors and prepare tubes and needles for them.
Autoclave all bottles and parts.
Prepare 1 L PBS è Follow the protocol.
Prepare 150ml MHB by adding 3.3gr powder into 150ml DI water.
Autoclave IV (LIQUID cycle, 121℃, 15min).
Prepare 5L of 0.33x Mueller Hinton Broth by adding 36.6gr
Mueller H powder into 5000ml ultrapure water.
Prepare 5L of 10x Mueller Hinton Broth by adding 11gr Mueller H
powder into 5000ml ultrapure water.
Autoclave I & II (LIQUID cycle, 121℃, 45-50 min).
Prepare Tetracycline solution è Follow the Protocol.

III.
IV.
C. Day 3:
I.
Prepare selective plates (For donor, recipient, and transconjugants).
è Follow the Protocol
II.
Prepare MIC plates.
III.
Add 30mg sodium azide to the MHB from Day 1.
IV. Add a J53 stock culture to the MHB.
D. Day 4:
I.
Wash overnight culture (16hr) with PBS.
II.
Set OD600nm on 0.4 for 10-fold and full MHB reactors,
respectively.
III.
Add washed-overnight J53 culture to the reactors. è 15ml.
IV. Start the pump (10 and 3.5 rpm for 0.45 and 0.15 hr-1 dilution rate,
respectively)
V. Measure OD and dilution rate regularly.
E. Day 5:
I.
Prepare 500ml MHB by adding 11gr powder into 500ml DI water
(2x).
II.
Autoclave (LIQUID cycle, 121℃, 25 min).
III.
Add kanamycin, rifampicin, and tetracycline to MHB media for
donor.
IV. Store media for donor in the refrigerator.
V. Prepare selective plates.
VI. Measure OD and dilution rate.
F. Day 6:
I. Prepare Tetracycline solution è Follow the Protocol
II. Prepare selective plates.
III. Prepare 2L PBS.
IV. Measure OD & dilution rate.
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G. Day 7:
I.
II.
III.
IV.
V.

Prepare 2L PBS.
Prepare selective plates.
Prepare MIC plates.
Measure OD & dilution rate.
Prepare Tet. 2 mg/L by adding 0.1ml of Tet. (256 mg/L) to 12.7ml
of water.

H. Day 8:
I.
Prepare selective plates.
II.
Measure OD & dilution rate.
III.
Add a transconjugant CV601 stock culture to the MHB containing
Ka, Tet, and Rif.
I. Day 9:
I. Wash transconjugant CV601 (10hr) by 3L PBS in a sterile caboy.
II. Add 15 ml of donor to each reactor to have 30ml final volume of
each reactor. By doing so, we can keep the dilution ratio constant.
III. Add tetracycline to the donor carboys to reach 10 µg/L of
tetracycline.
IV. Put transconjugant CV601 in PBS to the chemostat influent line
(2L).
J. Day 10:
I.
Take a 2-3ml sample after 16hr from each reactor.
II.
Make serial dilutions in sterile PBS.
III.
Plate the diluted sample on the selective plate which contains
sodium azide (200 mg/L) and Tetracycline (10 mg/L). Consider
minimum of three parallel plates of an appropriate dilution for each
sample.
IV. Plate samples on selective plates to control donor and recipient
numbers.
V. Incubate the plates at 35℃, UPSIDE DOWN, 2 days.
VI. Measure MIC è Follow Protocol.
K. Day 11:
I.
Take a 2-3ml sample after 24hr from each reactor.
II.
Make serial dilutions in sterile PBS.
III.
Plate the diluted sample on the selective plate which contains
sodium azide (200 mg/L) and Tetracycline (10 mg/L). Consider
minimum of three parallel plates of an appropriate dilution for each
sample.
IV. Plate samples on selective plates to control donor and recipient
numbers.
V. Incubate the plates at 35℃, UPSIDE DOWN, 2 days.
VI. Measure MIC è Follow Protocol.
L. Day 12:
I.
Take a 2-3ml sample after 48hr from each reactor.
II.
Make serial dilutions in sterile PBS.
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III.

Plate the diluted sample on the selective plate which contains
sodium azide (200 mg/L) and Tetracycline (10 mg/L). Consider
minimum of three parallel plates of an appropriate dilution for each
sample.
IV. Plate samples on selective plates to control donor and recipient
numbers.
V. Incubate the plates at 35℃, UPSIDE DOWN, 2 days.
VI. Measure MIC è Follow Protocol.
M. Day 13:
I.
Take a 2-3ml sample after 72hr from each reactor.
II.
Make serial dilutions in sterile PBS.
III.
Plate the diluted sample on the selective plate which contains
sodium azide (200 mg/L) and Tetracycline (10 mg/L). Consider
minimum of three parallel plates of an appropriate dilution for each
sample.
IV. Plate samples on selective plates to control donor and recipient
numbers.
V. Incubate the plates at 35℃, UPSIDE DOWN, 2 days.
VI. Measure MIC è Follow Protocol.
N. Day 14:
I.
Take a 2-3ml sample after 96hr from each reactor.
II.
Make serial dilutions in sterile PBS.
III.
Plate the diluted sample on the selective plate which contains
sodium azide (200 mg/L) and Tetracycline (10 mg/L). Consider
minimum of three parallel plates of an appropriate dilution for each
sample.
IV. Plate samples on selective plates to control donor and recipient
numbers.
V. Incubate the plates at 35℃, UPSIDE DOWN, 2 days.
VI. Measure MIC è Follow Protocol.
O. Day 15:
I.
Take samples from effluent line and make stock culture in glycerol
for future analysis.
II.
Autoclave all parts and carboy.
III.
Wash all tubs and connector/ use 70 percent ethanol for reactors and
carboys.
IV. Autoclave all parts one more time.

